|
|
||||||||
The Journal of Immunology, Vol 145, Issue 10 3372-3378, Copyright © 1990 by American Association of Immunologists
ARTICLES |
E Remold-O'Donnell and FS Rosen
Center for Blood Research, Children's Hospital, Boston, MA 02115.
Sialophorin (CD43) is the major surface mucin on many hematopoietic cells. It has been implicated in regulating the survival of T lymphocytes in the circulation, and its functions in vitro as the receptor of a T lymphocyte and monocyte activation pathway. The structure of CD43 was examined by protease treatment of lymphoblastoid cells bearing surface CD43. Trypsin treatment converts CD43 (apparent Mr 115,000) to species of apparent Mr 100,000 called T-100, which remains cell-associated; however, the mechanism of trypsin action was not clarified. Pancreatic elastase and Staphylococcus aureus V8 protease cleave CD43 at discrete extracellular sites. V8 protease generates two fragments, which together account for all properties and mass of the parent molecule. The COOH-terminal fragment V-90 (apparent Mr 90,000) consists of the intracellular and transmembrane regions and part of the extracellular region. The fragment V-30 (apparent Mr 30,000), which is released from the cell, comprises the NH2-terminal approximately 78 amino acids with attached oligosaccharides. V-30 contains the binding sites for the antibodies L2 and L10; the latter is the antibody that activates lymphocytes and monocytes. These findings subdivide the extracellular region of CD43 and indicate that the activation-inducing epitope is located in the most distal portion of the molecule. It is shown that CD43 is insensitive to all but very high concentrations of three proteases. Pretreatment with sialidase enhances sensitivity 13-fold for trypsin, 40-fold for S. aureus V8 protease, and 400-fold for elastase, suggesting that sialic acid influences the survival of surface CD43 molecules when cells are exposed to protease.
This article has been cited by other articles:
![]() |
R. C. Fuhlbrigge, S. L. King, R. Sackstein, and T. S. Kupper CD43 is a ligand for E-selectin on CLA+ human T cells Blood, February 15, 2006; 107(4): 1421 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Da Silva, A. Bharti, and C. S. Shelley hnRNP-K and Puralpha act together to repress the transcriptional activity of the CD43 gene promoter Blood, November 15, 2002; 100(10): 3536 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nemoto, H. Tada, and H. Shimauchi Disruption of CD40/CD40 ligand interaction with cleavage of CD40 on human gingival fibroblasts by human leukocyte elastase resulting in down-regulation of chemokine production J. Leukoc. Biol., September 1, 2002; 72(3): 538 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Shelley, J. M. Teodoridis, H. Park, O. C. Farokhzad, E. P. Bottinger, and M. A. Arnaout During Differentiation of the Monocytic Cell Line U937, Pur{alpha} Mediates Induction of the CD11c{beta}2 Integrin Gene Promoter J. Immunol., April 15, 2002; 168(8): 3887 - 3893. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. C. Farokhzad, J. M. Teodoridis, H. Park, M. A. Arnaout, and C. S. Shelley CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA Nucleic Acids Res., June 1, 2000; 28(11): 2256 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Sabri, M Soler, C Foa, A Pierres, A Benoliel, and P Bongrand Glycocalyx modulation is a physiological means of regulating cell adhesion J. Cell Sci., January 5, 2000; 113(9): 1589 - 1600. [Abstract] [PDF] |
||||
![]() |
M. Nieto, J. L. Rodriguez-Fernandez, F. Navarro, D. Sancho, J. M.R. Frade, M. Mellado, C. Martinez-A, C. Cabanas, and F. Sanchez-Madrid Signaling Through CD43 Induces Natural Killer Cell Activation, Chemokine Release, and PYK-2 Activation Blood, October 15, 1999; 94(8): 2767 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dri, E. Haas, R. Cramer, R. Menegazzi, C. Gasparini, R. Martinelli, P. Scheurich, and P. Patriarca Role of the 75-kDa TNF Receptor in TNF-Induced Activation of Neutrophil Respiratory Burst J. Immunol., January 1, 1999; 162(1): 460 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Fernandez, T. M. Hackeng, K. Kojima, and J. H. Griffin The Carbohydrate Moiety of Factor V Modulates Inactivation by Activated Protein C Blood, June 15, 1997; 89(12): 4348 - 4354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |